Evidence map›Paper›PMID 36559122›Full record

ReviewPharmaceutics2022

Direct and Reverse Pluronic Micelles: Design and Characterization of Promising Drug Delivery Nanosystems.

Almudena Naharros-Molinero, María Ángela Caballo-González, Francisco Javier de la Mata, Sandra García-Gallego

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Doubly protected ester prodrug of 5-aminolevulinic acid for enhanced cell uptake and photoinactivation.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  2. Article
  3. Article
  4. PluronicInternational journal of molecular sciences · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Novel Ultrasound-Responsive Amyloid Formulation.Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Almudena Naharros-MolineroBerlimed S.A., Francisco Alonso, 7, 28806 Alcalá de Henares, Spain.ORCID 0000-0002-9866-6366
María Ángela Caballo-GonzálezBerlimed S.A., Francisco Alonso, 7, 28806 Alcalá de Henares, Spain.
Francisco Javier de la MataDepartment of Organic and Inorganic Chemistry, Faculty of Sciences, and Research Institute in Chemistry "Andrés M. del Río" (IQAR), Universidad de Alcalá, 28801 Alcalá de Henares, Spain.ORCID 0000-0003-0418-3935
Sandra García-GallegoDepartment of Organic and Inorganic Chemistry, Faculty of Sciences, and Research Institute in Chemistry "Andrés M. del Río" (IQAR), Universidad de Alcalá, 28801 Alcalá de Henares, Spain.

Funding

Comunidad de Madrid CM/BG/2021-01Comunidad de Madrid CM/JIN/2021-003European Cooperation in Science and Technology N/AEuropean Regional Development Fund N/AMinistry of Universities BG20/00231Spanish Ministry of Science and Innovation DIN2020-011609
6 · The paper itself

Abstract

Pluronics are a family of amphiphilic block copolymers broadly explored in the pharmaceutical field. Under certain conditions, Pluronics self-assemble in different structures including nanosized direct and reverse micelles. This review provides an overview about the main parameters affecting the micellization process of Pluronics, such as polymer length, fragments distribution within the chain, solvents, additives and loading of cargo. Furthermore, it offers a guide about the most common techniques used to characterize the structure and properties of the micelles. Finally, it presents up-to-date approaches to improve the stability and drug loading of Pluronic micelles. Special attention is paid to reverse Pluronics and reverse micelles, currently underexplored in the literature. Pluronic micelles present a bright future as drug delivery agents. A smart design and thorough characterization will improve the transfer to clinical applications.

Indexed as

direct micelledrug deliveryPluronicpoloxamerreverse micelle

Identifiers

PMID36559122
PMCPMC9787366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.